Bolz Sven, Jappe Uta, Hartschuh Wolfgang
Universitäts-Hautklinik Heidelberg, D-69115 Heidelberg.
J Dtsch Dermatol Ges. 2008 Jan;6(1):44-7. doi: 10.1111/j.1610-0387.2007.06399.x. Epub 2007 Oct 1.
Perifolliculitis capitis abscedens et suffodiens (PCAS) is a rare scalp disease of unknown etiology which is hard to treat. It is often accompanied by scarring alopecia, acne conglobata, and recurrent fluctuant abscesses. PCAS belongs to the family of acne inversa (hidradenitis suppurativa). A 19-year-old man presented with PCAS for 2 years; multiple systemic antibiotic therapies and surgical approaches had shown no effect. Monotherapy with isotretinoin 80 mg daily for 4 weeks had not been successful. Combination therapy with dapsone 100 mg and isotretinoin 80 mg daily produced significant improvement. During 4 weeks of treatment significant clearing was achieved. Dapsone was reduced to 50 mg daily after 6 months, while isotretinoin was discontinued gradually. Now the patient is on dapsone 50 mg every other day and has remained free of recurrences for 6 months.
穿掘性蜂窝状头皮炎(PCAS)是一种病因不明的罕见头皮疾病,难以治疗。它常伴有瘢痕性脱发、聚合性痤疮和反复发作的波动性脓肿。PCAS属于反向痤疮(化脓性汗腺炎)家族。一名19岁男性患PCAS 2年;多种全身抗生素治疗和手术方法均无效。每天80毫克异维A酸单药治疗4周未成功。每日100毫克氨苯砜和80毫克异维A酸联合治疗取得了显著改善。在治疗的4周内病情明显好转。6个月后氨苯砜减至每日50毫克,而异维A酸逐渐停药。现在患者每隔一天服用50毫克氨苯砜,已6个月未复发。